Biotech | August 05, 2021
Biotech-PRIDE guidelines released
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Drug formulations and biologics make impressive gains
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The group now has 320 approvals and has so far filed over 400 ANDAs
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
Q1 FY22 consolidated revenue grew 6% to Rs. 1,808 crore from Rs. 1,712 crore in Q1 FY21. Q1 FY22 Net Profit was Rs. 84 crore (vs. Rs. 149 crore in Q1 FY21).
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
Subscribe To Our Newsletter & Stay Updated
